ArrowMark Colorado Holdings LLC lifted its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 41.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 484,617 shares of the company's stock after purchasing an additional 141,411 shares during the period. ArrowMark Colorado Holdings LLC owned 0.83% of Phreesia worth $12,193,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in PHR. Greenhouse Funds LLLP boosted its holdings in shares of Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after purchasing an additional 626,579 shares in the last quarter. Park West Asset Management LLC bought a new position in Phreesia in the fourth quarter valued at about $10,657,000. ExodusPoint Capital Management LP raised its stake in Phreesia by 448.6% during the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company's stock worth $4,402,000 after acquiring an additional 143,077 shares in the last quarter. Barclays PLC boosted its stake in shares of Phreesia by 120.4% in the 4th quarter. Barclays PLC now owns 209,209 shares of the company's stock valued at $5,264,000 after purchasing an additional 114,280 shares in the last quarter. Finally, Norges Bank acquired a new position in Phreesia during the 4th quarter worth approximately $2,804,000. 92.10% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts recently commented on the company. Citigroup lifted their price objective on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research note on Friday, January 10th. Canaccord Genuity Group increased their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday, March 13th. KeyCorp reduced their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Piper Sandler reaffirmed an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Finally, Needham & Company LLC reissued a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $31.33.
Get Our Latest Report on Phreesia
Insider Activity
In related news, COO Evan Roberts sold 16,005 shares of the company's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $480,150.00. Following the completion of the sale, the chief operating officer now directly owns 748,302 shares of the company's stock, valued at $22,449,060. This represents a 2.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Yvonne Hui sold 1,878 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $44,790.30. Following the transaction, the insider now owns 28,449 shares in the company, valued at approximately $678,508.65. This represents a 6.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 111,640 shares of company stock valued at $3,094,167. 5.80% of the stock is currently owned by company insiders.
Phreesia Trading Up 0.8 %
PHR traded up $0.20 on Friday, hitting $25.58. The company had a trading volume of 394,604 shares, compared to its average volume of 432,708. The company has a market cap of $1.50 billion, a PE ratio of -17.40 and a beta of 0.74. The business's fifty day simple moving average is $25.08 and its 200 day simple moving average is $24.64. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.
About Phreesia
(
Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
See Also
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
